Bilberry Pharmaceuticals Private Limited, a active private limited company, was established on 08 November 2016 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24299MP2016PTC041803. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Devendra Kumar Pathak (Director), Roshni Pathak (Director). Past directors included Amod Kumar Singh, Roshni Pathak. It holds ₹1.35 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Green Velly Flat No.C-507, Kanadiya Road,, Indore, Madhya Pradesh, 452001.
U24299MP2016PTC041803
041803
08 November 2016
₹1.00 M
₹0.40 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Bilberry Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devendra Kumar Pathak | Director | 08 Nov 2016 | Current |
| Roshni Pathak | Director | 17 Nov 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Nov 2016 | Past |
| Pramod Abcsdd | Additional Director | 20 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bilberry Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.1% increase. The company also saw a substantial fall in profitability, with a 65.69% decrease in profit. The company's net worth Soared by an impressive increase of 113.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Bilberry Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹13,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2024 | Tata Capital Housing Finance Limited | ₹1.35 Cr | Open |
Explore comprehensive loan charge details -
Bilberry Pharmaceuticals has a workforce of 21 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bilberry Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bilberry Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bilberry Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Bilberry Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
Progress on A charge with Tata Capital Housing Finance Limited amounted to Rs. 13.50 M with Charge ID 100851217 was registered on 24 Jan 2024. was documented.
The activity Roshni Pathak was appointed as a Director was appointed as a Director on 17 Nov 2016 & has been associated with this company since 9 years 11 days . was completed.
Progress on Devendra Kumar Pathak was appointed as a Director was appointed as a Director on 08 Nov 2016 & has been associated with this company since 9 years 20 days . was documented.
The activity Bilberry Pharmaceuticals Private Limited was registered on 08 Nov 2016 with Roc Gwalior & aged 9 years 20 days as per MCA records. was completed.
The CIN of Bilberry Pharmaceuticals Private Limited is U24299MP2016PTC041803.
Bilberry Pharmaceuticals Private Limited is headquartered at Green Velly Flat No.C-507, Kanadiya Road,, Indore, Madhya Pradesh, 452001.
Bilberry Pharmaceuticals Private Limited was incorporated on 08 November 2016.
The current directors of Bilberry Pharmaceuticals Private Limited are
The primary industry of Bilberry Pharmaceuticals Private Limited is Trade.
Bilberry Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bilberry Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Bilberry Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX